Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

WRI (Windber Research Institute) software deal for TissueInformatics:

This article was originally published in Clinica

Executive Summary

TissueInformatics has linked up with Windber Research Institute (WRI) in the US to develop software that could lead to faster, more accurate diagnosis of breast cancer and improved drug and other therapies for treatment. The partners are developing what Pittsburgh, Pennsylvania-based TissueInformatics claims is the industry's first software package for the quantitative structural analysis of cancerous breast tissue - a way of digitising breast tissue and then automatically analysing the images through highly accurate "machine vision". Current diagnostic research, says the firm, is primarily manual, making it subject to differences in human interpretation.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT060897

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel